A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Three‐dimensional (3D) tumor models have been established in various microfluidic systems for drug delivery and resistance studies in vitro. However, one of the main drawbacks of these models is non‐uniform distribution of cells, leaving regions with very low cell density within the 3D structures. As a result, molecular diffusion in the cell compartments is faster than that observed in solid tumors. To solve this problem, we developed a new technique for preparation of 3D tumor models in vitro. It was based on a microfluidic device containing three parallel channels separated by narrowly spaced posts. Tumor cells were loaded into the central channel at high density. To test the system, B16.F10 melanoma cells were perfusion‐cultured overnight and the resulting 3D structure was characterized in terms of viability, density, and morphology of cells as well as transport properties of small fluorescent molecules. Immediately upon loading of tumor cells, the cell density was comparable to those observed in B16.F10 tumor tissues in vivo; and the viability of tumor cells was maintained through the overnight culture. The tumor model displayed low extracellular space and high resistance to diffusion of small molecules. For membrane‐permeant molecules (e.g., Hoechst 33342), the rate of interstitial penetration was extremely slow, compared to membrane‐impermeant molecules (e.g., sodium fluorescein). This versatile tumor model could be applied to in vitro studies of transport and cellular uptake of drugs and genes. Biotechnol. Bioeng. 2012; 109:1326–1335. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797 · cited 2×
“, 2002), or utilized for drug screening (Bartholoma et al., 2005; Kunz-Schughart et al., 2004), each of these models has certain limitations.”
A novel 3D mammalian cell perfusion-culture system in microfluidic channels
Toh, Y.-C., Zhang, C., Zhang, J., Khong, Y. M., Chang, S., Samper, V. D., van Noort, D., Hutmacher, D. W., & Yu, H. (2007) · Lab on a Chip · doi:10.1039/b614872g · Cited by 414 · cited 1×
“…involve the use of hydrogels for cell trapping, embedment, or encapsulation to provide 3D structures (Bauer et al., 2010; Chen et al., 2010; Elliott and Yuan, 2011; Kim et al., 2007; Ng and Pun, 2008; Sung et al., 2011; Toh et al., 2005, 2007; Wlodkowic and Darzynkiewicz, 2010; Wong et al., 2008).”
Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids
Hsiao, A. Y., Torisawa, Y.-S., Tung, Y.-C., Sud, S., Taichman, R. S., Pienta, K. J., & Takayama, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.047 · Cited by 323 · cited 3×
“Most 3D tumor models are based upon spheroidal (Durand, 1990; Hsiao et al., 2009; Sutherland and Durand, 1976, 1984), or multicellular layer (MCL) (Grantab et al.”
Grantab, R., Sivananthan, S., & Tannock, I. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3077 · Cited by 254
Sung, K. E., Yang, N., Pehlke, C., Keely, P. J., Eliceiri, K. W., Friedl, A., & Beebe, D. J. (2011) · Integr. Biol. · doi:10.1039/c0ib00063a · Cited by 226 · cited 2×
“Current approaches to 3D culture of mammalian cells in microfluidic systems usually involve the use of hydrogels for cell trapping, embedment, or encapsulation to provide 3D structures (Bauer et al., 2010; Chen et al., 2010; Elliott and Yuan, 2011; Kim et al., 2007; Ng and Pun, 2008; Sung et al., 2011; Toh et al., 200…”
A gel-free 3D microfluidic cell culture system
Ong, S.-M., Zhang, C., Toh, Y.-C., Kim, S. H., Foo, H. L., Tan, C. H., van Noort, D., Park, S., & Yu, H. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.022 · Cited by 172 · cited 2×
“The main drawback of this gel-free technique is that the distribution of cells is dramatically heterogeneous in the culture compartment (Ong et al., 2008), with a large fraction of the compartment being occupied by cell culture medium.”
A microfluidic platform for 3-dimensional cell culture and cell-based assays
Kim, M. S., Yeon, J. H., & Park, J.-K. (2007) · Biomedical Microdevices · doi:10.1007/s10544-006-9016-4 · Cited by 166 · cited 1×
“…involve the use of hydrogels for cell trapping, embedment, or encapsulation to provide 3D structures (Bauer et al., 2010; Chen et al., 2010; Elliott and Yuan, 2011; Kim et al., 2007; Ng and Pun, 2008; Sung et al., 2011; Toh et al., 2005, 2007; Wlodkowic and Darzynkiewicz, 2010; Wong et al., 2008).”
Cited by
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Jeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S., & Kuh, H.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159013 · Cited by 287
Andersson, T. B., Kanebratt, K. P., & Kenna, J. G. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.685159 · Cited by 259
Organs-on-a-chip: a new tool for drug discovery
Polini, A., Prodanov, L., Bhise, N. S., Manoharan, V., Dokmeci, M. R., & Khademhosseini, A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.886562 · Cited by 223
Unger, C., Kramer, N., Walzl, A., Scherzer, M., Hengstschläger, M., & Dolznig, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.015 · Cited by 158
Metadata
- Authors
- Elliott, N. T., & Yuan, F.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2011-12-26
- Volume
- 109
- Issue
- 5
- Pages
- 1326-1335
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2145333969
- Cited by
- 29
- References
- 7
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.